Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 11, 2016CancerOpen Access

Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients

View Full Paper
Ask AI
Bookmark
Share

Authors

YSYoung Shin SongSeoul Metropolitan GovernmentJLJung‐Ah LimUniversity of TorontoHCHoon ChoiKangwon National University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Song et al. (2016) studied this question.

synapsesocial.com/papers/69d9d8620f32475823a3c855https://doi.org/10.1002/cncr.29934
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1TERT Promoter Mutations in Papillary Thyroid Microcarcinomas2015 · 107 citations
  2. 2High Prevalence of RAS Mutations in RET -Negative Sporadic Medullary Thyroid Carcinomas2011 · 243 citations
  3. 3Changes in the Clinicopathological Characteristics and Outcomes of Thyroid Cancer in Korea over the Past Four Decades2013 · 194 citations
  4. 4Korea's Thyroid-Cancer “Epidemic” — Screening and Overdiagnosis2014 · 1,256 citations
  5. 5Highly prevalent TERT promoter mutations in aggressive thyroid cancers2013 · 618 citations